Utilisation Patterns and Treatment Outcomes of EGFR-Tyrosine Kinase Inhibitors in EGFR-mutant Advanced Lung Carcinoma in the Pakistani-Asian Population: A Real-world Data Study.

However, it did not reach statistical significance due to the small sample size ( P = 0.131).

also in 111,027 other papers

sion no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY-NC-SA Introduction Lung cancer remains the leading cause of cancer death, with an estimated 1.8 million deaths per year, according to GLOBOCAN 2020.[ 1 ] Many developing countries are experiencing an increasing trend in the incidence of lung cancer.[ 2 ] Low- and middle-income countries constitute more than 50% of all lung cancer deaths annually.

also in 63,971 other papers